The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Research
Categorie
Archives
The prevalence of neurodegenerative disorders is one of the most important current threats to aging in Europe. Obesity is known to have effects on neurocognition and gut microbiota composition, and the microbiota is an important but under-recognized element in...
With its unique combination of scientific expertise, R&D skills and state-of-the-art technologies, Enterosys is set to become a leading preclinical contract research organization (CRO) in the market. Enterosys has a technological lead in the investigation of the...
These are days of R&D partnership in the health sector. The 9th edition of AFSSI Connexions will take place on July 5/6 in Lyon, France. Two days of congress and convention networking, a true annual french marketplace for R&D in Life Sciences! Several plenary...
Non-alcoholic liver disease (NAFLD) is considered the hepatic manifestation of the metabolic syndrome (which includes abdominal obesity, hyperglycemia, dyslipidemia and hypertension), and the leading cause of liver disease. NAFLD, like the metabolic syndrome, is a...
The General Assembly of the AFSSI was held on April 8th. On this occasion, Anne Abot, scientific director of Enterosys, was elected to the board of directors along with representatives of two other companies: Cell&Co and Vibiosphen. Their objective is to bring...